Candesartan: all 67 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary HypercholesterolemiaEnrolling by invitationNCT06646354Phase 3
- Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)RecruitingNCT05321875Phase 3
- Effect of Some Drugs on Liver FibrosisRecruitingNCT03770936Phase 3
- Candesartan's Effects on Alzheimer's Disease And Related BiomarkersCompletedNCT02646982Phase 2Results posted
- CAndesartan vs LIsinopril Effects on the BRainCompletedNCT01984164Phase 2Results posted
- Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy SubjectsCompletedNCT01976572Phase 1Results posted
- Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life DepressionTerminatedNCT01794455Phase 4Results posted
- CR Aim #2 - AT1 Receptor Blockade & ACE Inhibition Effect on Humoral FunctionCompletedNCT01678794Phase 1/2Results posted
- The RAS, Fibrinolysis and Cardiopulmonary BypassCompletedNCT00607672Phase 4Results posted
- The Antihypertensives and Vascular, Endothelial and Cognitive Function TrialCompletedNCT00605072Phase 2Results posted
- Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs AloneCompletedNCT00391846Phase 4Results posted
- Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP)CompletedNCT00348686Phase 4Results posted
- DIabetic Retinopathy Candesartan Trials.CompletedNCT00252720Phase 3Results posted
- DIabetic Retinopathy Candesartan TrialsCompletedNCT00252694Phase 3Results posted
- Candesartan for Migraine Prevention:CompletedNCT04574713Phase 2
- Candesartan as an Adjunctive Treatment for Bipolar DepressionWithdrawnNCT04430959Early Phase 1
- Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast CancerStatus unknownNCT04429633Not applicable
- Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)Status unknownNCT04351724Phase 2/3
- Drug-drug-interaction Study of Candesartan, Amlodipine and AtorvastatinCompletedNCT04245046Phase 1
- Candesartan in Peripheral NeuropathyTerminatedNCT03688633Phase 2
- Adiposity and Endothelin Receptor FunctionActive, not recruitingNCT03583866Early Phase 1
- Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)CompletedNCT02988362Phase 1
- Expression and Function of the Renin-Angiotensin System in the EsophagusCompletedNCT02879721Early Phase 1
- Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - BCompletedNCT02811731Phase 1
- Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - ACompletedNCT02801526Phase 1
- Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension ControlWithdrawnNCT02521246Phase 3
- Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension ControlWithdrawnNCT02521233Phase 3
- A Dose Selection Trial of CKD-330 in Patients With Essential HypertensionStatus unknownNCT02206165Phase 2
- Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg)CompletedNCT02186496Phase 1
- Pharmacokinetic Drug Interaction Between Candesartan and RosuvastatinCompletedNCT02079506Phase 1
- CKD-330 Drug-Drug Interaction Study (Candesartan)CompletedNCT02064621Phase 1
- RAS Quantification in Patients With Aliskiren or CandesartanCompletedNCT01827202Phase 4
- The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR)TerminatedNCT01766505Phase 4
- To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart FailureCompletedNCT01682564Phase 4
- Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) BlockerStatus unknownNCT01444833Not applicable
- Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer TherapyCompletedNCT01434134Phase 2
- Pivotal Bioequivalence FDC Nifedipine / Candesartan vs. Loose Combination of Single Components, FedCompletedNCT01350609Phase 1
- Cognitive Function and Electrocardiogram (ECG) During Hypoglycemia and Blockade of the Renin-angiotensin SystemCompletedNCT01116180Not applicable
- An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine DependenceCompletedNCT01062451Phase 1
- Angiotensin Receptor Blockade as an Anti-Fibrotic Intervention in Patients With Chronic Hepatitis CWithdrawnNCT00930995Phase 2
- Evaluation of the Pharmacokinetic Interaction Between Candesartan and Felodipine After Ingestion of a Specific MealCompletedNCT00905333Phase 1
- Candesartan Versus Propranolol for Migraine PreventionCompletedNCT00884663Phase 2/3
- Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.CompletedNCT00775840Phase 3
- Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.CompletedNCT00775814Phase 4
- The Potential of Candesartan to Retard the Progression of Aortic StenosisStatus unknownNCT00699452Phase 3
- Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Preserved)CompletedNCT00634712Phase 3
- Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative)CompletedNCT00634400Phase 3
- Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Added)CompletedNCT00634309Phase 3
- Angiotensin-II Blockade in Mitral RegurgitationCompletedNCT00587470Phase 4
- Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus LercanidipineStatus unknownNCT00564057Phase 4
- CCB Safety Study in Treatment of Hypertension of ADPKDStatus unknownNCT00541853Phase 4
- A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive PatientsCompletedNCT00538486Phase 4
- CHANCE - Candesartan in Hypertrophic CardiomyopathyStatus unknownNCT00430833Phase 2
- Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus HydrochlorothiazideCompletedNCT00360178Phase 3
- Safety and Effects of Ramipril Combined With CandesartanCompletedNCT00356395Phase 4
- Diabetes Type 1, Treatment Study Atacand/Placebo After Kidney BiopsyStatus unknownNCT00328302Phase 4
- Angiotensin II Antagonism of TGF-Beta 1CompletedNCT00320970Not applicable
- Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese SubjectsTerminatedNCT00319202Phase 4
- Effects of Sodium Intake on (PK/PD) Relationship of a Single Dose of a Renin Angiotensin System-BlockerCompletedNCT00310778Phase 1
- Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic StenosisStatus unknownNCT00294775Phase 3
- Effectiveness of Candesartan and Telmisartan on Morning Hypertension in Japanese Obese PatientsStatus unknownNCT00288717Not applicable
- Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and PlaceboCompletedNCT00282178Phase 2
- Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney DiseaseStatus unknownNCT00235287Phase 4
- Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive DrugsStatus unknownNCT00192803Phase 4
- Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) TrialCompletedNCT00139386Phase 4
- Candesartan in the Prevention of Relapsing Atrial FibrillationCompletedNCT00130975Phase 3
- Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)Status unknownNCT00108706Phase 4